Clinical Investigators Discuss Existing and Emerging Treatment Strategies for Patients with Ovarian, Cervical and Endometrial Cancer
Robert L Coleman, MD and Ursula Matulonis, MD
Moderated by Dr. Neil Love
Presented by Research to Practice
On May 18 and 20, 2020, Research to Practice hosted two unique live webinars designed to review key developments in the management of gynecologic cancers. The first program focused on the role of PARP inhibition in the management of ovarian cancer and was followed by a session looking at immune checkpoint inhibitors and other novel therapies in the management of ovarian, endometrial and cervical cancer. Both programs featured a stellar panel of clinical investigators discussing recent data sets, including those that emerged from the SGO 2020 Annual Meeting on Women’s Cancer Webinar Series, the results of surveys completed by 25 experts and relevant cases from the panelists’ practices.
In case you missed either or both of these programs, Research to Practice is pleased to offer four additional one-hour sessions intended to provide an overview of the salient takeaways and important management pearls from the two longer events.
All times listed are Central Daylight Time (CDT)
